OralCDx India Private Limited, a 100% subsidiary of OralCDx USA, is a specialty anatomic pathology laboratory that utilizes its patented, minimally invasive biopsy and tissue analysis technologies to increase the detection of the precursors of Oral Cancer. The OralCDx Computer Assisted Brush Biopsy Analysis Method has received the prestigious ‘Seal of Acceptance' from the Council on Scientific Affairs of the American Dental Association (ADA).

India has one of the highest incidence of Oral cancer in the world, directly linked to the consumption of tobacco in various forms. Oral CDx aspires to lead the crusade against Oral Cancer, by providing access to pioneering ‘Brush Test' technology, through healthcare professionals across India.